Which mineralocorticoid receptor antagonists (MRAs; ie, steroidal, nonsteroidal) are currently indicated or used for treating heart failure with midrange ejection fraction (HFmrEF) and HF failure ...

The obese models however, developed heart failure with preserved ejection fraction (HFpEF), proving that a combination of stressors give rise to the disease and providing a good model for further ...

STAT asked 11 experts, including the FDA commissioner, why the world's wealthiest nation is doing so poorly on cardiovascular ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

TX45 is being developed for the treatment of Group 2 PH-HFpEF. “These topline Phase 1a ... and we look forward to sharing the full trial results at the AHA Scientific Sessions later this year ...

Experts And Viewpoints, August 30, 2021 ESC 2021 Incremental, Not Monumental, Win for Empagliflozin in HFpEF The modest effects ... December 15, 2020 AHA 2020 EARLY-AF and STOP AF Put ...

The trial was done in adults with obesity and heart failure with preserved ejection fraction (HFpEF). The data, posted online on August 1, has not yet been published in a peer-reviewed journal.

It's also been studied for people with heart failure.Ribose is a sugar molecule that's made naturally in the body from blood ...

Vapes containing nicotine may increase the risk of heart failure, according to a new study, adding on to previous research ...

In heart failure with preserved ejection fraction, a slower heart rate is presumed ... Experts And Viewpoints, December 15, 2022 AHA 2022 STRONG HF: More Beats Less After Discharge for Heart ...